Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund launched on May 1, ...

CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 17, Morgan Stanley increased its price target on CRISPR Therapeutics AG ...

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 2, Wedbush analyst Laura Chico increased the firm’s price target on ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 5, Anupam Rama from JPMorgan increased the price target on Apellis ...

Hims & Hers stock surged 45% after a Novo Nordisk GLP-1 deal—see which ETFs hold HIMS most, and how the rally may impact fund performance.

Duquesne Family Office's billionaire boss meaningfully pared down two high-flying stocks in the fourth quarter and made a ...

Linnaeus Therapeutics closed a $4.48 million equity round and won up to $22 million from a federal health agency. The company is studying pathways that may influence aging and disease.

Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology and strategic licensing in oncology.

Fintel reports that on March 10, 2026, HC Wainwright & Co. initiated coverage of SpyGlass Pharma (NasdaqGS:SGP) with a Buy recommendation. What is the Fund Sentiment? There are 1 funds or institutions ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...

Ladenburg, Germany Tuesday, March 10, 2026, 13:00 Hrs [IST] ...